Altered Cytoplasmic-to-Nuclear Ratio of Survivin Is a Prognostic Indicator in Breast Cancer

PURPOSE: Survivin (BIRC5) is a promising tumor biomarker. Conflicting data exist on its prognostic effect in breast cancer. These data may at least be partly due to the manual interpretation of immunohistochemical staining, especially as survivin can be located in both the nucleus and cytoplasm. Qua...

詳細記述

保存先:
書誌詳細
出版年:Clin Cancer Res
主要な著者: Brennan, Donal J., Rexhepaj, Elton, O’Brien, Sallyann L., McSherry, Elaine, O’Connor, Darran P., Fagan, Ailís, Culhane, Aedín C., Higgins, Desmond G., Jirstrom, Karin, Millikan, Robert C., Landberg, Goran, Duffy, Michael J., Hewitt, Stephen M., Gallagher, William M.
フォーマット: Artigo
言語:Inglês
出版事項: 2008
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7295090/
https://ncbi.nlm.nih.gov/pubmed/18451232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-07-1760
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料